TOKYO (Reuters) - Takeda Pharmaceutical Co Ltd on Friday posted a 27.9 percent rise in third-quarter operating profit,starry night by anne sexton supported by strong sales of its drugs for bowel disease and multiple myeloma.
Profit reached 112.5 billion yen ($1.03 billion) in October-December, Japan's biggest drugmaker said in a stock exchange filing.
The company also maintained its full-year operating profit forecast at 268.9 billion yen. That compared with the 240.7 billion yen average of 10 analyst estimates compiled by Refinitiv.
Takeda completed a $59 billion deal to acquire peer Shire in January, joining the ranks of the world's biggest 10 drugmakers by sales - and also becoming one of the world's most indebted.
Proceeding with its plan to sell up to $10 billion in non-core assets to slash the debt, Takeda aims to focus on five key areas: oncology, gastroenterology, neuroscience, rare disease, and plasma derived therapies.
The drugmaker is also looking at vaccines as a potential core business. It said earlier this week its experimental dengue vaccine is safe and effective at preventing all four types of the mosquito-borne disease.
Takeda has already started divesting. It announced on Monday that it would sell a set of 21 assets, including its headquarters building in Osaka, and book about 38 billion yen in proceeds for the year through March.
During nine months ending in December, sales of Entyvio, a treatment for Crohn's disease and ulcerative colitis, hit 201 billion yen, up 34.4 percent on year. Ninlaro, which treats multiple myeloma, rose 34.5 percent.
Takeda does not disclose quarterly sales of each product.
(Reporting by Takashi Umekawa; Editing by Christopher Cushing)
View comments
顶: 74153踩: 15
【starry night by anne sexton】Takeda's third-quarter profit rises 28 percent on strong sales of main drugs
人参与 | 时间:2024-09-29 08:13:54
相关文章
- Insider Buying: The Domino's Pizza Group plc (LON:DOM) CEO & Director Just Bought UK£201k Worth Of Shares
- Iran watchdog passes law on hardening nuclear stance, halting UN inspections
- Pompeo says U.S. considering welcoming Hong Kong people, entrepreneurs
- Have Insiders Been Buying IKONICS Corporation (NASDAQ:IKNX) Shares?
- ECB working on lending scheme for coronavirus-hit SMEs -sources
- How Good Is Harvia Oyj (HEL:HARVIA), When It Comes To ROE?
- Manufacturing data helps lift stocks, U.S. dollar bounces
- Genius Brands International Promotes Michael Jaffa to Chief Operating Officer
- Suzan Craig and Tahi Restore Nature and Make 100 Percent Natural, Genuine Honey
- As Biotech Thrives On Vaccine Hopes, Traders Look Into The Sector's Diversity
评论专区